Research demonstrates activated B cell responses in ulcerative colitis, suggesting new avenues for treatment.
Background IgA-producing B cells maintain gut homeostasis and control the entry of commensal bacteria and pathogens. Different B cell subtypes are expanded in the colon of patients with ulcerative colitis (UC). In a mouse model of colitis, activated markers have been detected on a large proportion of gut B cells. Activation signals driven by different receptors on B cells are primarily dependent on the phosphoinositide 3-kinase δ (PI3Kδ) pathway. Aims To determine the effects of colonic inflammation on the activated B cell responses in UC patients and in a preclinical model of UC. Methods Human transcriptomic data from UC patient and control colon biopsies were used for single-cell RNA sequencing analysis. Mice with a gain-of-function (GOF) mutation in PI3Kδ were crossed with Mb1-Cre transgenic mice to generate Cre+ mice with hyperactive B cells and Cre- littermates as controls. Thirty six male Cre+ and Cre- mice were treated with 1.5% (w/v) dextran sulfate sodium (DSS) for 6 days, followed by 8 days of recovery (regular water). Disease activity index was monitored daily. B cell phenotypes were assessed by flow cytometry in the Peyer’s patches and mesenteric lymph nodes (MLN). Serum levels of inflammatory and anti-inflammatory cytokines were measured by mesoscale. Levels of IgA, M, G1, and G2b in the colonic lumen and serum were determined by ELISA. Results In UC patients, a large subset of mature B cells overexpressed CD86, which was coexpressed with HLA-DRB5, HLA-DPA1, and HLA-DQA1. Gene ontology analysis of mature B cells in UC patients also indicated enrichment in pathways related to mitochondrial ATP synthesis and B cell receptor signalling. In the preclinical model of colitis, PI3Kδ GOF Cre+ mice with hyperactive B cells exhibited faster recovery and gained weight compared to Cre- littermates. Serum levels of IL-10 were significantly higher in colitic Cre+ compared to the colitic Cre- groups, but there was no statistical difference in TNF-α, IFN-γ, and IL-12/IL-23p40 serum levels. Flow cytometry data showed a significant increase in the percentage of IL-10+ B cells in the MLNs and Peyer’s patches of Cre+ compared to the Cre- mice. Furthermore, Cre+ mice in colitic condition had more IgM and IgG1&2b subclasses and less IgA levels in the colonic lumen and serum compared to the colitic Cre- mice. Conclusions Intestinal inflammation in UC patients leads to mature B cell activation with the antigen-presenting phenotype and mitochondrial respiration. In acute colitis, constitutive PI3Kδ activation in B cells accelerates recovery by inducing a subset of B cells to produce anti-inflammatory cytokines and antibodies, which may support intestinal immune protection. These findings may guide the development of new UC therapies.
No takes yet. Share an insight, caveat, or question.
Sabzevary et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: